Particle.news
Business ❯ Corporate Governance ❯ Investor Relations
Securities Fraud Stock Market Financial Reporting Securities Securities Regulations Securities Offerings Altimmune, Inc. Stock Performance James Hardie Industries Securities Regulation Telix Pharmaceuticals Trade Desk, Inc. Stock Acquisition Market Reactions Stockholder Actions Stockholder Rights Product Launches KBR, Inc. Bumble Inc. BellRing Brands IPO Performance Revance Therapeutics Replimune Group, Inc. Stockholder Communication Pinterest, Inc. DoubleVerify Holdings, Inc. Grocery Outlet Holding Corp. uniQure N. V. Stellantis N.V. Financial Disclosures Iovance Biotherapeutics NuScale Power Corporation Snowflake Inc. NASDAQ Tronox Holdings plc Shareholder Rights Capricor Therapeutics BellRing Brands, Inc. Skyworks Solutions, Inc. Securities Transactions Agilon Health, Inc. Securities Exchange Act Shareholder Activism Medpace Holdings Inc. Savara Inc. CarMax, Inc. Pharmaceutical Companies Enphase Energy Vistagen Therapeutics LifeMD, Inc. Cytokinetics Atara Biotherapeutics Soleno Therapeutics Baxter International Inc. Market Performance Shanghai Stock Exchange Regulatory Compliance Mereo BioPharma Group Disclosure Obligations C3.ai, Inc. Five Below, Inc. Chipotle Mexican Grill DBV Technologies Pharmaceutical Industry Trip.com Group Limited
Law firms say the company concealed trial‑design and site‑monitoring problems that plaintiffs blame for the failed Phase 3 result and heavy investor losses.
